After that date, it may still be safe and effective, but there is not enough evidence to support beyond that timeframe
While not classified as a controlled substance, it is regulated differently for research, therapeutic, and athletic contexts
The innovation underlying dual and even triple receptor agonists lies in their single-molecule architecture, which represents a significant advancement in peptide bioengineering
Its very similar to managing other chronic conditions, like high blood pressure
The improvement in ESS and AHI caused by GLP-1 RA is correlated with weight loss, BMI, and reduced waist circumference [45, 49, 82]